Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …

Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive
research over the last several decades, the survival rates for GBM have not improved and …

Glioblastoma multiforme (GBM) is the most common primary malignant Central Nervous
System cancer, responsible for about 4% of all deaths associated with neoplasia …

Simple Summary Glioblastoma multiforme (GBM) are among the most lethal tumors. The
highly invasive nature and presence of GBM stem cells, as well as the blood brain barrier …

Glioblastoma (GBM) is a very aggressive CNS tumor with poor prognosis. Current treatment
lacks efficacy indicating that new therapeutic approaches are needed. One of these new …

Glioblastoma (GBM) is one of the most aggressive and deadliest central nervous system
tumors, and the current standard treatment is surgery followed by radiotherapy with …

Glioblastoma is one of the most aggressive central nervous system malignancies with high
morbidity and mortality. Current clinical approaches, including surgical resection …

Glioblastoma (GB) is the most lethal type of primary tumor in the central nervous system.
Current treatments include surgical resection followed by chemotherapy and radiotherapy …

Simple Summary Glioblastoma multiforme (GBM) is one of the belligerent neoplasia that
metastasize to other brain regions and invade nearby healthy tissues. However, the …

Glioblastoma is the most common primary, malignant brain tumor that remains uniformly
lethal in nearly all cases as a result of extreme cellular heterogeneity, treatment resistance …